Mutations in dihydrofolate reductase variants with amino acid substitutions at residues Phe31 [19], Arg70 [20], Leu22 [21,22], Val115 [23] and Phe34 [24] existing in folate binding site have been detected in MTX-resistant cancer cell lines. The gene discussed is DHFR; the disease is cancer.